Home NDC 63672-0051 Levocetirizine dihydrochloride
Product NDC 63672-0051
11-digit product format 636720051
Labeler code 63672
Product ID 63672-0051_c1f4c652-5aa3-4f4f-a201-9d540a058557
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Levocetirizine dihydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Synthon Pharmaceuticals, Inc.
Application ANDA090229
Marketing category ANDA
Marketing start 2010-11-26
Marketing end 0000-00-00
Substance LEVOCETIRIZINE DIHYDROCHLORIDE
Active strength 5 mg/1
Pharmacologic classes Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 52 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63672-0051-2 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63672-0051-3 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63672-0051-0 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63672-0051-1 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63672-0051-2 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63672-0051-3 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63672-0051-0 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63672-0051-1 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 63672-0051-0 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 63672-0051-0 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 63672-0051-0 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 63672-0051-0 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 63672-0051-0 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 63672-0051-0 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 63672-0051-0 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 63672-0051-0 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 63672-0051-0 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 63672-0051-0 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 63672-0051-0 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 63672-0051-0 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 63672-0051-0 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 63672-0051-0 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 63672-0051-0 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 63672-0051-0 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 63672-0051-0 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 63672-0051-0 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 63672-0051-0 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product I Inactivated by FDA 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 63672-0051-0 I Inactivated by FDA 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A090229-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A090229-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL AB 2010-11-26 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Levocetirizine dihydrochloride ACTIVE INGREDIENT SOD6A38AGA LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1 Levocetirizine ACTIVE MOIETY 6U5EA9RT2O LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1 magnesium stearate INACTIVE INGREDIENT 70097M6I30 LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1 polyethylene glycol 400 INACTIVE INGREDIENT B697894SGQ LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63672-0051 LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 10 Legacy NDC 20250529_c0b39c8e-9e43-43bb-9151-b0c3c29e84fa.zip 63672-0051 LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [SYNTHON PHARMACEUTICALS, INC.] 1 Legacy NDC 20101211_2f42fc80-ae39-4301-b140-36e59d71666e.zip